BusinessSurefire Receives Regulatory Approval for Infusion Systems and Guiding Catheters in MexicoBy Nasdaq OMXMar 20, 2017, 10:00 AM UTC
BusinessClinical Data Shows Surefire Technology Achieved 79% Objective Response versus 37% Using a Standard Microcatheter in Treating Primary Liver CancerBy Nasdaq OMXMar 8, 2017, 11:00 AM UTC
BusinessSurefire Medical Launches New Flexion Guiding Catheter with Nitinol Tip for Better Shape Retention, Improved Back-up SupportBy Nasdaq OMXMar 6, 2017, 11:00 AM UTC
BusinessMats Wahlström Joins Surefire Medical Board of DirectorsBy Nasdaq OMXNov 30, 2016, 11:00 AM UTC
BusinessSurefire Medical Receives Grant to Pursue Phase 1b Clinical Trial of CAR-T Immunotherapy Delivery through Precision Infusion SystemBy Nasdaq OMXNov 15, 2016, 11:00 AM UTC
